Biofrontera BFRI Cash Flow Statement (2020-2026)

NASDAQ BFRI
$0.80 0.00 (-0.21%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Biofrontera Quarterly Cash Flow Statement

Periods 23 quarters
Latest Jun 2026

Biofrontera cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 23 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M5.64M-0.60M
Depreciation and DepletionDep. & Depletion
0.03M0.03M0.02M0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.04M0.03M0.06M0.04M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.10M0.10M0.10M0.11M0.10M0.10M0.10M0.11M0.10M0.10M0.10M0.11M0.10M0.11M0.00M0.00M0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.03M0.02M0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.04M0.03M0.06M0.04M
Share-based CompensationStock Comp.
0.13M0.52M0.55M0.40M0.38M0.35M0.26M0.21M0.23M0.23M0.20M0.29M0.30M0.24M0.10M0.24M0.29M0.20M
Gains from Equity InvestmentsGains Equity
-2.94M-1.48M-2.21M-0.79M0.00M-0.01M0.00M0.00M0.00M0.00M
Asset Writedowns and ImpairmentWritedown
0.00M0.00M0.00M
Other non-cash itemsOther Non-Cash
0.12M0.70M11.50M-8.58M-5.37M-3.39M-0.08M-0.99M-0.28M-0.40M-5.44M4.14M-5.44M0.68M-0.06M-0.29M-0.15M0.29M-0.20M-0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
0.01M0.29M1.82M1.43M-3.08M-0.46M2.18M0.38M-1.87M1.70M1.33M-1.58M-0.01M1.40M0.49M-1.33M-0.09M-0.95M4.27M
Change in InventoryChange Inventory
-1.70M-1.28M-0.98M0.41M4.04M3.28M-4.92M-0.50M8.12M1.28M-5.15M-4.00M-2.96M2.58M0.15M-0.12M-2.50M0.30M0.87M
Change in Account PayablesChange Payables
-1.83M-1.61M1.40M0.59M-2.69M-1.98M1.32M2.83M
Change in Accured ExpensesChange Accured Exp.
0.22M12.38M0.81M-1.11M2.39M2.24M-7.13M-0.79M4.17M2.76M-12.49M-0.26M-0.63M1.06M-0.39M0.31M1.22M0.75M-1.66M
Change in Other Operating AssetsOther Assets Change
0.03M-0.35M15.43M-3.58M-5.72M0.03M0.12M-1.89M-0.21M-1.90M2.51M0.12M-0.09M-5.24M0.19M0.22M0.68M-0.05M1.56M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.13M-0.12M-0.12M-0.28M-0.17M-0.17M-0.18M-0.18M-0.18M-0.19M-0.18M-0.14M
Other Working Capital ChangesOther WC Changes
-0.03M0.35M-15.43M3.58M5.72M-0.03M-0.12M1.76M0.08M1.78M-2.80M-0.29M-0.07M5.06M-0.37M-0.40M-0.88M-0.12M-1.70M
Cash from OperationsCash from Ops.
-1.07M-1.22M-20.99M-2.11M0.11M-5.93M-8.27M-3.70M-10.33M-2.00M-8.87M-3.33M-4.72M-1.26M-1.00M-4.12M-3.08M-3.80M-2.40M
Investing Activities
Capital ExpendituresCapex
0.00M0.01M0.01M0.03M0.00M0.00M0.01M-0.01M0.06M0.00M-0.05M0.00M0.00M0.00M0.00M
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.01M-0.01M-0.03M0.00M0.00M-0.01M0.01M-0.06M0.00M0.05M0.00M0.00M0.00M0.00M
Sale and Maturity of InvestmentsInvestments Sold
0.36M0.06M0.06M
Cash from Investing ActivitiesCash from Investing
0.00M-0.01M-0.01M-0.03M-3.03M-2.09M-0.01M0.18M0.38M0.07M0.00M0.00M0.00M0.00M3.00M
Financing Activities
Debt Issuance and Repayment
Short-Term Debt issuancesST Debt Issuance
7.85M11.70M
Short-Term Debt repaymentsST Debt Repayment
7.26M9.50M1.86M2.15M0.30M
Current Debt
0.59M2.21M-1.86M-2.15M-0.30M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.59M2.21M-1.86M-2.15M-0.30M
Change in Capital Stock
Common Stock IssuedStock Issued
4.63M7.66M
Net Shares Issued and RepurchasedNet Shares Issued
4.63M7.66M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
2.35M
Net Equity Issued and RepurchasedNet Equity Issued
4.63M7.66M2.35M
Other financing activitiesOther financing
-0.12M
Cash from Financing ActivitiesCash from Financing
-0.12M43.83M4.63M0.59M6.71M5.80M5.28M-0.30M4.05M2.35M
Additional items
Change in Cash
-1.59M-1.34M22.83M-2.12M9.49M-4.35M-10.36M-3.70M-9.05M-1.03M-2.08M2.47M0.56M-1.51M3.03M-4.12M5.45M-3.82M2.98M
Ending Cash Balance
3.25M1.91M24.74M22.63M32.11M27.77M17.41M13.71M4.65M3.62M1.54M4.02M4.58M3.07M6.11M1.99M7.44M3.62M6.59M4.86M
Free Cash FlowFCF
-1.07M-1.22M-21.00M-2.12M0.08M-5.93M-8.27M-3.71M-10.33M-2.00M-8.86M-3.38M-4.72M-1.26M-0.95M-4.12M-3.08M-3.80M-2.40M
Net Cash FlowNCF
-1.07M-1.34M22.83M-2.12M0.08M-4.33M-10.36M-3.71M-10.15M-1.03M-2.08M2.47M0.56M-1.55M3.05M-4.12M-3.08M-3.80M2.95M
Interest Paid
0.00M0.01M-0.01M0.09M1.17M0.53M0.02M0.01M0.00M0.00M
Income Taxes PaidTaxes Paid
0.00M0.01M0.05M0.03M0.00M0.02M-0.01M0.00M0.00M0.00M

Biofrontera Cash Flow Statement API

Pull Biofrontera's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BFRI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY